FURONAAF
Generic: Cefuroxime + Clavulanic AcidAntibiotics
- Product information at a glance
- Available strengths
- 250 mg62.5 mg500 mg125 mg31.25 mg
- Dosage form
- Film-coated tablet, Powder, Suspension
- Pack sizes
- Each box contains 2 pouches, each pouch containing 1x7 tablets in Alu-Alu blister pack.Each box contains 1 pouch, each pouch containing 1x7 tablets in Alu-Alu blister pack.Each bottle contains powder for the preparation of 70 ml suspension.
Strengths, dosage forms and pack sizes are taken from the product composition and packing information below.
Composition
- Furonaaf-CV 250 Tablet: Each film coated tablet contains 250 mg of Cefuroxime as Cefuroxime Axetil USP and 62.5 mg of Clavulanic Acid as Diluted Potassium Clavulanate BP.
- Furonaaf-CV 500 Tablet: Each film coated tablet contains 500 mg of Cefuroxime as Cefuroxime Axetil USP and 125 mg of Clavulanic Acid as Diluted Potassium Clavulanate BP.
- Furonaaf-CV 70 ml Powder for Suspension: After reconstitution, each 5 ml suspension contains 125 mg of Cefuroxime as Cefuroxime Axetil USP and 31.25 mg of Clavulanic Acid as Diluted Potassium Clavulanate BP.
Indications
Furonaaf-CV is indicated for treatment of:
- Pharyngitis and Tonsillitis
- Middle Ear Infections (Otitis Media)
- Sinus Infections (Maxillary Sinusitis)
- Pneumonia and Lower Respiratory Infections
- Bronchitis (Acute and Chronic Exacerbations)
- Skin and Skin-Structure Infections
- Urinary Tract Infections (UTI)
Presentation & packing
- Furonaaf-CV 250 Tablet: Each box contains 2 pouches, each pouch containing 1x7 tablets in Alu-Alu blister pack.
- Furonaaf-CV 500 Tablet: Each box contains 1 pouch, each pouch containing 1x7 tablets in Alu-Alu blister pack.
- Furonaaf-CV Powder for Suspension: Each bottle contains powder for the preparation of 70 ml suspension.
Leaflet & prescribing information
Distributor enquiry
Speak to the NAAFCO Pharma export and distribution team about supply, pack sizes and availability of FURONAAF.


















